QIANHAI HEALTH (00911) announced its performance for the year 2025, with a net profit of 5.941 million Hong Kong dollars, representing a year-on-year increase of 353.2%.

20:58 18/03/2026

Qianhai Health (00911) released its annual performance as of December 31, 2025, with revenue of HKD 677 million, a YoY increase of 30.3%; net profit of HKD 5.941 million, a YoY increase of 353.2%; basic earnings per share of 3.51 HK cents.

QIANHAI HEALTH (00911) announced its annual performance for the year ending December 31, 2025, with revenue of HK$677 million, a year-on-year increase of 30.3%; net profit of HK$5.941 million, a year-on-year increase of 353.2%; and basic earnings per share of HK$0.351. The increase in revenue for the year was mainly driven by the significant increase in market prices for NAND flash wafers and other electronic components throughout the year. The growth was partially offset by a decrease in sales volume of electronic components due to the industry-wide shortage.

NUOBIKAN (02635) subsidiary Huibo Hang'an received an investment of 29 million yuan and will fully promote the smart airport business.

CHINA 33MEDIA (08087) suggests splitting its shares

The controlling shareholder of Zhejiang Great Shengda Packaging (603687.SH), Xinsengda, intends to transfer 44,002,600 shares to Hechuang Xinyuan through an agreement.

NUOBIKAN (02635) subsidiary Huibo Hang'an received an investment of 29 million yuan and will fully promote the smart airport business.

CHINA 33MEDIA (08087) suggests splitting its shares

The controlling shareholder of Zhejiang Great Shengda Packaging (603687.SH), Xinsengda, intends to transfer 44,002,600 shares to Hechuang Xinyuan through an agreement.